Home > Insider Trading > Filing (0001140361-16-087436)

Filing Details

Accession Number:: 0001140361-16-087436
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-21 17:09:22
Reporting Period:: 2016-11-17

Filing Date:: 2016-11-21
Accepted Time:: 2016-11-21 17:09:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366007	Bruce Telkamp	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Ceo Of Healthpocket, Inc.*	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2016-11-17	31,720	$10.27	183,281	No	4	S	Direct
Class A Common Stock	Disposition	2016-11-18	26,890	$10.00	156,391	No	4	S	Direct
Class A Common Stock	Disposition	2016-11-21	390	$10.56	156,001	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$6.77	2021-05-25	84,000	84,000	Direct
Class A Common Stock	Stock Appreciation Rights	$6.77	2021-05-25	42,000	42,000	Direct
Class A Common Stock	Stock Appreciation Rights	$12.13	2021-07-14	10,000	10,000	Direct
Class A Common Stock	Stock Appreciation Rights	$4.95	2022-07-01	40,000	40,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-05-25	84,000	84,000	Direct
2021-05-25	42,000	42,000	Direct
2021-07-14	10,000	10,000	Direct
2022-07-01	40,000	40,000	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually received ranged from $10.25 to $10.675. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price.
These stock-settled stock appreciation rights were granted under the Plan and will vest as follows: (i) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $12.00 per share for the preceding 30 consecutive trading days, and (ii) 42,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $16.00 per share for the preceding 30 consecutive trading days, all subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were previously granted under the Plan and will vest (either wholly or partially) based on the extent to which certain financial performance targets established by the Company's Board of Directors are achieved for the 2016 fiscal year.
These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan (the "Plan") and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.